neostigmine methylsulfate
Generic: neostigmine methylsulfate
Labeler: dr.reddys laboratories incDrug Facts
Product Profile
Brand Name
neostigmine methylsulfate
Generic Name
neostigmine methylsulfate
Labeler
dr.reddys laboratories inc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
neostigmine methylsulfate 1 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
43598-945
Product ID
43598-945_7abc7438-a58a-cc92-8fba-36e92389bf58
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216291
Listing Expiration
2026-12-31
Marketing Start
2022-07-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43598945
Hyphenated Format
43598-945
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
neostigmine methylsulfate (source: ndc)
Generic Name
neostigmine methylsulfate (source: ndc)
Application Number
ANDA216291 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 1 mg/mL
Packaging
- 10 BLISTER PACK in 1 CARTON (43598-945-58) / 1 SYRINGE, GLASS in 1 BLISTER PACK (43598-945-11) / 3 mL in 1 SYRINGE, GLASS
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "7abc7438-a58a-cc92-8fba-36e92389bf58", "openfda": {"upc": ["0343598945583", "0343598945118"], "unii": ["98IMH7M386"], "rxcui": ["2105413"], "spl_set_id": ["12575d1a-a2c2-37b2-0dcf-31e58bbc2a10"], "manufacturer_name": ["Dr.Reddys Laboratories Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 CARTON (43598-945-58) / 1 SYRINGE, GLASS in 1 BLISTER PACK (43598-945-11) / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "43598-945-58", "marketing_start_date": "20220725"}], "brand_name": "Neostigmine Methylsulfate", "product_id": "43598-945_7abc7438-a58a-cc92-8fba-36e92389bf58", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "43598-945", "generic_name": "Neostigmine Methylsulfate", "labeler_name": "Dr.Reddys Laboratories Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Neostigmine Methylsulfate", "active_ingredients": [{"name": "NEOSTIGMINE METHYLSULFATE", "strength": "1 mg/mL"}], "application_number": "ANDA216291", "marketing_category": "ANDA", "marketing_start_date": "20220725", "listing_expiration_date": "20261231"}